Resumo

VALLDEPERAS, X.; BONILLA, R.; ROMANO, M.R.  e  CAMARA, J. de la. Use of intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to choroidal rupture. Arch Soc Esp Oftalmol [online]. 2011, vol.86, n.11, pp.380-383. ISSN 0365-6691.

Case report: A 28 year-old male attended our Emergency Department with a traumatic choroidal rupture and macular haemorrhage. After pneumatic displacement of the haemorrhage with C₃F₈ and tissue plasminogen activator, the haemorrhage was reabsorbed and visual acuity (VA) improved. Three months later the patient presented with decreased VA and a juxtafoveal choroidal neovascularisation (CNV) that was treated with intravitreal bevacizumab. One year after a single bevacizumab injection the CNV remained inactive, with a final VA of 0.5. Discussion: Intravitreal bevacizumab injection is a new and effective treatment for traumatic CNV. In our patient, in contrast to other aetiologies, the CNV needed no more than one Avastin^® injection to be inactivated, after one year of follow-up.

Palavras-chave : Recombinant tissue plasminogen activator (rTPA); Pneumatic displacement; Submacular haemorrhage; Ocular traumatism; Bevacizumab; Choroidal rupture; Choroidal neovascularisation.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )